Unknown

Dataset Information

Microtoxin for Improving Pore Size, Skin Laxity, Sebum Control, and Scars: A Roundtable on Integrating Intradermal Botulinum Toxin Type A Microdoses Into Clinical Practice.


ABSTRACT:

Background

In aesthetic clinical practice, botulinum toxin type A (BoNT-A) is best known for its use as a neuromodulator for the treatment of dynamic facial lines; however, when injected intradermally as microdroplets, BoNT-A can improve skin quality and overall skin appearance.

Objectives

To discuss key aspects of microtoxin use in clinical practice and provide expert guidance on utilization.

Methods

As part of a continuing medical education lecture series and roundtable, the authors discussed key aspects of microtoxin patient selection, injection technique, and safety.

Results

The experiences of expert faculty are shared here. Clinical experience is consistent with reported data. Microtoxin can be used to reduce pore size, sebum production, rosacea, acne, and

SUBMITTER: Fabi SG 

PROVIDER: S-EPMC10481112 | biostudies-literature | 2023 Aug

REPOSITORIES: biostudies-literature